HER2-IN-8
HER2-IN-8 is a HER-2 inhibitor extracted from patent WO2021179274A1 compound 107. HER2-IN-8 can be used for the research of cancer and inflammation[1].
Product Specifications
CAS Number
2704630-49-7
UNSPSC
12352005
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/her2-in-8.html
Solubility
10 mM in DMSO
Smiles
COC1=C(C2=C(N=CN=C2NC3=CC(C)=C(C=C3)OC4=CN5N=CN=C5N=C4)C=N1)O[C@@H]6CCN(CC6(F)F)C
Molecular Formula
C26H25F2N9O3
Molecular Weight
549.53
References & Citations
[1]Zhou D, et, al. ErbB RECEPTOR INHIBITORS AS ANTI-TUMOR AGENTS. WO2021179274A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ErbB2/HER2
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1087403-01 0.02 mg (E-Coli)
Recombinant Solibacter usitatus Serine--tRNA ligase (serS)
Sign In for Pricing
View Details MBS1087403-02 0.02 mg (Yeast)
Recombinant Solibacter usitatus Serine--tRNA ligase (serS)
Sign In for Pricing
View Details 
MBS1087403-03 0.1 mg (E-Coli)
Recombinant Solibacter usitatus Serine--tRNA ligase (serS)
Sign In for Pricing
View Details 
MBS1087403-04 0.1 mg (Yeast)
Recombinant Solibacter usitatus Serine--tRNA ligase (serS)
Sign In for Pricing
View Details MBS1087403-05 0.02 mg (Baculovirus)
Recombinant Solibacter usitatus Serine--tRNA ligase (serS)
Sign In for Pricing
View Details